
Stream Biomedical: Innovating neuroprotective therapies for stroke, brain injury, and spinal cord treatment.
Stream Biomedical is a product development company dedicated to innovating neuroprotective and neuroreparative therapies. The company focuses on addressing unmet therapeutic needs for individuals suffering from neurological trauma or degeneration, including acute stroke, traumatic brain injury, spinal cord injury, Alzheimer's, vascular dementia, and Parkinson's. Stream Biomedical holds licenses for intellectual property related to the therapeutic use of its biologics, aiming to preserve brain function and improve patient outcomes.
Notable affiliated individuals and investors have not been publicly disclosed. However, Stream Biomedical has achieved significant milestones in developing its proprietary biologic therapies. The company's impact lies in its potential to revolutionize treatment options for severe neurological conditions, offering hope for improved recovery and quality of life for patients. Through its innovative approach, Stream Biomedical aims to make substantial contributions to the field of neurotherapeutics.

Neuraly
neuralymed.com

Premier Biomedical

Symic Biomedical

Regennova
regennova.com

Therini Bio
therinibio.com

Stramsen Biotech

ReNetX Bio
renetx.com

Strm.Bio
strm.bio

BioStream Technologies
biostreamtech.com

ZZ Biotech
zzbiotech.com

Reservoir Neuroscience
reservoirneuro.com

BioHealthonomics

Niche Biomedical

Nura Bio
nurabio.com

Spinogenix
spinogenix.com
Companies similar to Stream Biomedical include Neuraly, Premier Biomedical, Symic Biomedical and Regennova.
Stream Biomedical was founded in 2016.
Stream Biomedical's headquarters is located in Houston, TX, US.
Stream Biomedical's most recent funding round was for $21.5M (USD) in January 2022.
As of Jan 7, 2022, Stream Biomedical has raised a total of $21.5M (USD).
Stream Biomedical has 8 employees as of Feb 5, 2024.